Safety Study of SLC-391 in Subjects With Solid Tumors
Clinical trial NCT03990454 · COMPLETED
Trial details
- NCT number
- NCT03990454
- Sponsor
- SignalChem Lifesciences Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-17
- Primary completion
- 2023-06-30
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.